How Did We End Up Using a Quadruple Guided Therapy Combining At Least Two Antibiotics with a PPI to Eradicate Helicobacter pylori?

Maxime Pichon; Julie Cremniter; Christophe Burucoa

doi:10.3390/jcm11175216

How Did We End Up Using a Quadruple Guided Therapy Combining At Least Two Antibiotics with a PPI to Eradicate Helicobacter pylori?

J Clin Med. 2022 Sep 3;11(17):5216. doi: 10.3390/jcm11175216.

Authors

Maxime Pichon^{1

2}, Julie Cremniter^{1

2}, Christophe Burucoa^{1

2}

Affiliations

¹ CHU Poitiers, Infectious Agents Department, Bacteriology Laboratory, 86021 Poitiers, France.
² INSERM U1070 Pharmacology of Antimicrobial Agents and Antibiotic Resistance, University of Poitiers, 86073 Poitiers, France.

Abstract

Since the discovery of Helicobacter pylori, and even if the species is frequently susceptible to many antibiotics in vitro, only six of them (amoxicillin, clarithromycin, metronidazole, tetracycline, levofloxacin, and rifabutin) and bismuth salts could be considered as effective in vivo to eliminate H pylori and have been used in recommended eradication treatments [...].

Publication types

Editorial

Grants and funding

This research received no external funding.